My Life CagriSema 12 mg combines 6 mg Cagrilintide + 6 mg Semaglutide in a 2.6 mL pen (240 clicks). Dual-action fat loss and appetite control.
Unlock the power of dual-agonist fat loss.
Order My Life CagriSema 12 mg today and take control of your metabolism for lasting transformation.
My Life – Cagrisema
My Life CagriSema 12 mg is a dual-agonist metabolic peptide that combines two powerful hormones — Cagrilintide (an amylin analogue) and Semaglutide (a GLP-1 receptor agonist) — working synergistically to deliver breakthrough results in appetite control, fat loss, and glucose regulation.
Cagrilintide slows gastric emptying and enhances satiety, while Semaglutide boosts insulin sensitivity and suppresses hunger signals. Together, they deliver amplified and sustained weight-management effects, helping users achieve superior metabolic outcomes compared to single-pathway GLP-1 therapy.
Each 2.6 mL pen with 240 clicks provides convenient, consistent, once-weekly dosing.
Suggested Dosage Progression
(240 clicks / 2.6 mL pen)
Week Range Clicks per Week Approx. Dose (mg) Phase / Notes Weeks 1 – 4 5 clicks 0.25 mg Start – allow body to adapt Weeks 5 – 8 10 clicks 0.5 mg Increase – appetite regulation begins Weeks 9 – 12 15 clicks 0.75 mg Increase – metabolic activation Weeks 13 – 16 20 clicks 1.0 mg Increase – active fat-loss phase Week 17 + 24 clicks 1.2 mg Maintain – long-term stability *Each click equals approximately 0.05 mg total actives (Cagrilintide + Semaglutide). Adjust dose only under professional guidance.
